Select Page

EMERALD-1 (Morphic Therapeutic)

Study Drug: MORF-057 Study Drug administration: Oral Principal Investigator: Jay Desai Disease: Moderate to Severe Ulcerative Colitis Inclusion criteria: endoscopically and clinically active UC, treatment naïve OR failed biologics (include TNF antagonists,...